Evaluation of intralesional 0.2% ciprofloxacin as a treatment for cutaneous leishmaniasis

Eastern Mediterranean Health Journal

Volumn 16, Issue 1, 2010, Pages 89-93

  Al Hamdi, K I ^a   Awad, A H ^a   Moker, H M ^a  

^a UNIVERSITY OF BASRAH   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; HYPERTONIC SALIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCAR; SCAR FORMATION; SCHOOL CHILD; SKIN DEFECT; SKIN LEISHMANIASIS; TREATMENT OUTCOME; WOUND HEALING;

EID: 76749117687     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.1.89     Document Type: Article

References (22)

1. Definition of Leishmania infection. MedicineNet.com [website] (http://www.medterms.com/script/main/art.asp?articlekey=15243, accessed 21 April 2009).
2. Mandell GL, Douglas RG, Bennett JE. Principles and practice of infectious disease, 3rd ed. New York, Churchill Livingstone, 1990:975.
3. Al-Mahdawi SK. Rapid survey of an outbreak of cutaneous leishmaniasis. Bulletin of endemic diseases, 1988, 29:23-6.
4. Kadir MA. A study on cutaneous leishmaniasis in Arbil. Bulletin of endemic diseases, 1988, 29:51-6.
5. Najim RA. Treatment of cutaneous leishmaniasis by zinc sulphate [PhD thesis]. College of Mediicne, University of Baghdad, Baghdad, Iraq, 1996.
6. Lachmann PJ et al. Clinical aspects of immunology. Volume 3. Hong Kong, Maple-Vial Book, 1993:1575-97.
7. Markle WH, Makhoul K. Cutaneous leishmaniasis: recognition and treatment. American family physician, 2004, 69:1455-60.
8. Burns T et al. Rook's textbook of dermatology, 7th ed. Volume 2. Oxford, Blackwell Scientific, 2004.
9. Beck JW, Davies JE. Medical parasitology. St Louis, Mosby, 1981 (Translated into Arabic by the University of Mosul, Iraq, 1985).
10. Sharquie KE. A new intralesional therapy of cutaneous leishmaniasis with hypertonic sodium chloride solution. Baghdad, Iraq, Iraqi Central Organization for Specification and Quality Control/Patent Section, 1993 (Patent No. 2459).
11. Sharquie KE, Waiz MM, Assir MA. Intralesional metronidazole: a new treatment of cutaneous leishmaniasis [diploma dissertation]. College of Mediicne, University of Baghdad, Baghdad, Iraq, 1996.
12. Jarallah HM. Effect of some plant extracts and antibiotics with histopathological study on Leishmania major strain [MSc thesis]. College of Education, University of Basra, Basra, Iraq, 2003.
13. Colle J et al. Mackie and Macartney practical medical microbiology, 14th ed. New York, Churchill Livingstone, 1996:978.
14. Bryceson ADM, Hay RJ. Parasitic worms and protozoa, In: Champion RH et al., eds. Textbook of dermatology, 6th ed. Volume 2. Oxford, Blackwell Scientific, 1998.
15. Waller GD, Renwick AG, Hillier K. Medical pharmacology and therapeutics. Philadelphia, WB Saunders, 2001:653.
16. Ahmed AM. Case report: chronic cutaneous leishmaniasis successfully treated with pentostam. Iraqi medical journal, 1982, 29:99-101.
17. Dowlati Y. Treatment of cutaneous leishmaniasis (old world). Clinics in dermatology, 1996, 14:513-7.
18. Al-Shaikhly IAS, Sayidmarie KH. Treatment of cutaneous leish maniasis by local hyperthermia. Bulletin of endemic diseases, 1985, 26:93-8.
19. Sharquie KE, Al-Talib K, Chu AC. Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony. British journal of dematology, 1988, 119:53-7.
20. Velez I et al. Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis: a randomized, controlled trial. Annals of internal medicine, 1997, 126:232-6.
21. Gorbach SL, Bartlett JB, Blacklow NR. Infectious disease, 1st ed. Philadelphia, WB Saunders, 1992:2115.
22. Furet YX, Pechère JC. Newly documented antimicrobial activity of quinolones. European journal of clinical microbiology and infectious diseases, 1991, 10:249-54.